Supriya Lifescience ramps up capacity and global readiness for next phase of growth
Supriya Lifescience has built a strong global presence in Active Pharmaceutical Ingredients. What has guided this journey?
Our…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
API
Separate license regime for bulk drugs, API and KSMs, under govt’s consideration
The government is considering a separate licensing framework for bulk drugs, active pharmaceutical ingredients (APIs) and key…
HRV Pharma and MetroChem forge strategic CDMO alliance
HRV Global Life Sciences (HRV Pharma), India’s first integrated Virtual API and Pharmtech company, announced a unique,…
Lilly to build $6.5 billion API manufacturing facility in Texas
Eli Lilly and Company has announced its plan to build a new $6.5 billion manufacturing facility at Generation Park in Houston,…
Aparna Pharmaceuticals secures EUGMP certification for Pydibhimavaram facility
Aparna Pharmaceuticals, a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and Advanced Drug Intermediates,…
Lilly partners with API to launch a CME for obesity
The Obesity Gurukul program will aim to offer a structured and immersive learning experience for over 20,000 healthcare…
Alembic Pharmaceuticals receives USFDA EIR for API-III facility in Gujarat
The inspection at the Karakhadi-based manufacturing site was conducted by the USFDA from 17 to 21 March 2025
Supriya Lifescience expands solar power capacity with 5 MWp facility in Maharashtra
Company strengthens renewable energy commitment with latest solar project
Lupin receives “A-” leadership rating from CDP for climate change and water security
Lupin improves its CDP scores, reflecting progress in sustainability efforts, carbon footprint reduction, and water management
Axplora invests €50 million in Mourenx Site to expand API and biologics manufacturing
The investment will enhance peptide purification capabilities and support GLP-1 therapy production for diabetes and obesity…